Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973.
[2]
Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49(1 Suppl):S1-37.
[3]
Sagransky MJ, Maguire HC Jr. Acne conglobata. In: Fitzpatrick's Dermatology in General Medicine. 8th ed. McGraw-Hill; 2012.
[4]
Kraft JK, Freiman A. Management of acne. CMAJ. 2011;183(7):E430-E435.
[5]
Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet. 2012;379(9813):361-372.
[6]
Nast A, Dréno B, Bettoli V, et al. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol. 2012;26 Suppl 1:1-29.
[7]
Molin S, Ruzicka T, Herzinger T. Acne conglobata successfully treated with adalimumab. J Eur Acad Dermatol Venereol. 2015;29(6):1175-1176.
[8]
Sampedro-Raña M, García-Martínez P, Pérez-Gestal B. Bimekizumab in the treatment of severe acne conglobata. Br J Dermatol. 2023;188(5):678-679.